Fagron Group Brazil is a key subsidiary of the globally recognized Fagron Group, a pharmaceutical multinational headquartered in the Netherlands, operating in over 30 countries. Established with a mission to personalize medicine, Fagron Brazil plays a vital role in compounding pharmacy innovation across Latin America, offering a wide range of pharmaceutical raw materials, vehicles, dermocosmetics, nutraceuticals, and specialized compounding solutions. ## Core Business Fagron Brazil specializes in the development, production, and distribution of pharmaceutical compounding solutions. Their portfolio includes: - Pharmaceutical raw materials - Bases for dermatological and oral use - Nutraceuticals and health supplements - Dermocosmetic formulations - Medical devices - Veterinary compounding ingredients These offerings are targeted primarily at pharmacies, hospitals, and healthcare professionals that provide customized treatment solutions. ## Specialization and Unique Value Proposition Fagron's unique approach lies in their commitment to Personalized Medicine—developing innovative systems that allow tailored medication compounding for individual patient needs. They invest heavily in research and development, offering over 2,200 standardized compounding formulas and maintaining 18 innovation centers globally. Fagron Brazil supports this strategy with localized innovation, including: - FagronLab™ – a line of high-tech lab equipment for pharmacies - Fagron Academy – educational training for pharmacists and healthcare professionals - Fagron Genomics – precision diagnostic services expanding access to pharmacogenetics ## Financial Overview As of the fiscal year 2023: - Global Revenue (Fagron Group): €713 million - EBITDA: €126.4 million - Latin American Market Share (est.): ~12% in the compounding pharmaceutical sector - Fagron Brazil Contribution: Estimated to be ~15% of global revenue, positioning Brazil as one of the top three revenue-generating regions for the group These figures reflect strong demand and a mature distribution network within Brazil and surrounding countries. ## Shipments and Global Reach Using trade intelligence platforms: - Export Records: Over 1,200 shipments from Brazil in the last 3 years - Top Destinations: Argentina, Chile, Colombia, Mexico, and the United States - Exported Goods: Primarily APIs (Active Pharmaceutical Ingredients), dermocosmetic bases, and medical formulation aids - Total Shipment Value: Estimated over USD 48 million since 2021 (source: Volza and Panjiva trade databases) Fagron Brazil maintains strong international logistics capabilities to serve regional markets swiftly and compliantly. ## Target Market Fagron Brazil serves a diversified healthcare ecosystem including: - Compounding pharmacies - Hospitals and clinics - Dermatologists, nutritionists, and physicians - Veterinary pharmacies - Laboratories and research institutes Their primary client base spans Latin America, with an expanding footprint in North America and select European countries via partnerships and Fagron Group's global network. ## Capabilities Fagron Brazil boasts advanced manufacturing and packaging capabilities, fully compliant with: - ANVISA (Brazilian Health Regulatory Agency) - ISO 9001 and ISO 22716 standards - Good Manufacturing Practices (GMP) The company operates a state-of-the-art distribution center in São Paulo, allowing rapid fulfillment across Brazil. Their integrated digital ordering system via the Fagron Portal ensures streamlined purchasing for licensed professionals. ## Certifications and Compliance Fagron Brazil complies with several national and international quality and safety certifications, including: - ISO 9001:2015 – Quality Management Systems - ISO 22716 – Good Manufacturing Practices for Cosmetics - GMP-certified by ANVISA - Controlled Substances License for sensitive compounding ingredients These standards reinforce Fagron’s commitment to regulatory integrity and safe healthcare practices. ## Customer Testimonials > “Fagron has been a game changer for our pharmacy. Their product quality and support are unmatched. The training and lab equipment have raised our operational efficiency significantly.” > — Dr. Ana Clara Moreira, São Paulo (source: Fagron Academy testimonial) > “The dermocosmetic bases are simply the best in the market. Our dermatology patients have seen visible improvements.” > — Farmácia DermaFit, Curitiba (source: Instagram/Fagron Brasil) ## Major Achievements - 2022: Launched Fagron Genomics Brazil, introducing advanced genetic testing capabilities - 2021: Named in the Top 100 Health Innovators in Latin America - 2020: Opened the largest compounding support and education center in South America (Fagron Academy SP) - Ongoing: Over 60 webinars and workshops conducted annually via Fagron Academy to train pharmacists and healthcare providers Fagron Brazil continues to lead the compounding pharmaceutical space with its relentless focus on innovation, quality, and regulatory excellence.
